FARMINGDALE, N.Y.--(BUSINESS WIRE)--Misonix, Inc. (Nasdaq: MSON), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, today announced that its Sonora Medical Systems, Inc. subsidiary was awarded U.S. Patent No. 7,278,289 by the Director of the United States Patent and Trademark Office. The patent awarded to Sonora, a leading supplier of aftermarket products, services and test equipment to the medical imaging ultrasound and MRI markets, is the first for its unique FirstAssist ultrasound system testing device and pertains to the methods and apparatus for testing a diagnostic ultrasound system having multiple transmitter elements and multiple receiver elements. FirstAssist was designed and developed for the purposes of testing the accuracy and ensuring the clinical efficacy of medical ultrasound imaging devices.
